Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to teszler.
van Santen HM, Tytgat GA, van de Wetering MD, van Eck-Smit BL, Hopman SM, van der Steeg AF, Nieveen van Dijkum EJ, van Trotsenburg AS. van Santen HM, et al. Among authors: van de wetering md, van trotsenburg as, van der steeg af, van eck smit bl. Thyroid. 2013 Feb;23(2):249. doi: 10.1089/thy.2012.0149.rs. Epub 2012 Nov 27. Thyroid. 2013. PMID: 23185983 No abstract available.
Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM, van den Akker ELT, Verwaaijen EJ, Fiocco M, Rensen N, van Litsenburg RRL, Pluijm SMF, Zwaan CM, van Santen HM, Pieters R, Evers AWM, Grootenhuis MA, van den Heuvel-Eibrink MM. van Hulst AM, et al. Among authors: van den heuvel eibrink mm, van santen hm, van litsenburg rrl, van den akker elt. Eur J Cancer. 2023 Jul;187:124-133. doi: 10.1016/j.ejca.2023.03.039. Epub 2023 Apr 7. Eur J Cancer. 2023. PMID: 37149961 Free article. Clinical Trial.
Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review.
Mulder RL, Kremer LC, van Santen HM, Ket JL, van Trotsenburg AS, Koning CC, Schouten-van Meeteren AY, Caron HN, Neggers SJ, van Dalen EC. Mulder RL, et al. Among authors: van santen hm, van dalen ec, van trotsenburg as. Cancer Treat Rev. 2009 Nov;35(7):616-32. doi: 10.1016/j.ctrv.2009.06.004. Epub 2009 Jul 28. Cancer Treat Rev. 2009. PMID: 19640651 Review.
Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
van Santen HM, Tytgat GA, van de Wetering MD, van Eck-Smit BL, Hopman SM, van der Steeg AF, Nieveen van Dijkum EJ, van Trotsenburg AS. van Santen HM, et al. Among authors: van de wetering md, van trotsenburg as, van der steeg af, van eck smit bl. Thyroid. 2012 Jun;22(6):643-6. doi: 10.1089/thy.2011.0464. Epub 2012 Apr 23. Thyroid. 2012. PMID: 22524499
Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.
Clement SC, van Eck-Smit BL, van Trotsenburg AS, Kremer LC, Tytgat GA, van Santen HM. Clement SC, et al. Among authors: van santen hm, van trotsenburg as, van eck smit bl. Pediatr Blood Cancer. 2013 Nov;60(11):1833-8. doi: 10.1002/pbc.24681. Epub 2013 Jul 6. Pediatr Blood Cancer. 2013. PMID: 23832530
Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.
Clement SC, van Rijn RR, van Eck-Smit BL, van Trotsenburg AS, Caron HN, Tytgat GA, van Santen HM. Clement SC, et al. Among authors: van santen hm, van trotsenburg as, van eck smit bl, van rijn rr. Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):706-15. doi: 10.1007/s00259-014-2967-4. Epub 2014 Dec 16. Eur J Nucl Med Mol Imaging. 2015. PMID: 25512056
183 results